We consider the design of a two-arm superiority cluster randomised controlled trial (RCT) with a continuous outcome. We detail Bayesian inference for the analysis of the trial using a linear mixed-effects model. The treatment is compared to control using the posterior distribution for the treatment effect. We develop the form of the assurance to choose the sample size based on this analysis, and its evaluation using a two loop Monte Carlo sampling scheme. We assess the proposed approach, considering the effect of different forms of prior distribution, and the number of Monte Carlo samples needed in both loops for accurate determination of the assurance and sample size. Based on this assessment, we provide general advice on each of these choices. We apply the approach to the choice of sample size for a cluster RCT into post-stroke incontinence, and compare the resulting sample size to those from a power calculation and assurance based on a Wald test for the treatment effect. The Bayesian approach to design and analysis developed in this paper can offer advantages in terms of an increase in the robustness of the chosen sample size to parameter mis-specification and reduced sample sizes if prior information indicates the treatment effect is likely to be larger than the minimal clinically important difference.
翻译:我们考虑使用连续结果的双臂优势集群随机控制试验(RCT)的设计。我们详细介绍使用线性混合效应模型分析试验的贝叶西亚推论。这种处理与使用治疗效果的后端分布进行控制比较。我们根据这一分析,开发了选择样本规模的保证形式,并使用两个环形蒙特卡洛取样计划进行了评估。我们评估了拟议方法,考虑到不同形式先前分布的影响,以及在精确确定保证和样本规模的两个循环中需要的蒙特卡洛样品的数量。我们根据这一评估,就其中每一种选择提供了一般建议。我们采用这种方法选择集束RCT样本规模的选择,以适应后不连续状态,并将由此得出的样本规模与基于治疗效果Wald测试的动力计算和保证的样本数量进行比较。本文中制定的巴伊西亚设计和分析方法,从提高选定样本规模的稳健性以比较误标度和样本规模缩小的样本规模方面提供了好处,如果先前的信息表明临床影响可能比重要的临床影响小得多的话。